07:00 , Sep 26, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Lysine-specific demethylase 2 (KDM2); KDM7 In vitro and cell culture studies identified a hydroxamate-based inhibitor of KDM2 and KDM7 that...